[PDF][PDF] Immune processes in the pathogenesis of Parkinson's disease-a potential role for microglia and nitric oxide
A Czlonkowska, I Kurkowska-Jastrzebska… - Medical Science …, 2002 - researchgate.net
It has been known for many years that immune system alterations occur in Parkinson's
disease (PD). Changes in lymphocyte populations in cerebrospinal fluid and blood …
disease (PD). Changes in lymphocyte populations in cerebrospinal fluid and blood …
Control of coronary blood flow during exercise
JD Tune, KN Richmond… - … biology and medicine, 2002 - journals.sagepub.com
Under normal physiological conditions, coronary blood flow is closely matched with the rate
of myocardial oxygen consumption. This matching of flow and metabolism is physiologically …
of myocardial oxygen consumption. This matching of flow and metabolism is physiologically …
Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects
BA Kingwell, M Formosa, M Muhlmann, SJ Bradley… - Diabetes, 2002 - Am Diabetes Assoc
Nitric oxide (NO) synthase inhibition reduces leg glucose uptake during cycling without
reducing leg blood flow (LBF) in young, healthy individuals. This study sought to determine …
reducing leg blood flow (LBF) in young, healthy individuals. This study sought to determine …
Balance between myogenic, flow-dependent, and metabolic flow control in coronary arterial tree: a model study
AJM Cornelissen, J Dankelman… - American Journal …, 2002 - journals.physiology.org
Myogenic response, flow-dependent dilation, and direct metabolic control are important
mechanisms controlling coronary flow. A model was developed to study how these control …
mechanisms controlling coronary flow. A model was developed to study how these control …
Nitric oxide modulates myocardial oxygen consumption in the failing heart
YJ Chen, JH Traverse, R Du, MX Hou, RJ Bache - Circulation, 2002 - Am Heart Assoc
Background—Endogenous nitric oxide (NO) has been reported to inhibit oxygen
consumption in the normal heart, so that nonselective inhibition of NO synthase (NOS) …
consumption in the normal heart, so that nonselective inhibition of NO synthase (NOS) …
Tonal nitric oxide and health–a free radical and a scavenger of free radicals
Basal/tonal nitric oxide (NO) production helps maintain particular microenvironments, ie,
vascular. Besides NO's function in controlling the activation state of various tissues such as …
vascular. Besides NO's function in controlling the activation state of various tissues such as …
Metabolic regulation of coronary vascular tone: role of endothelin-1
D Merkus, DJ Duncker… - American Journal of …, 2002 - journals.physiology.org
Coronary tone is determined by a balance between endogenously produced endothelin and
metabolic dilators. We hypothesized that coronary vasodilation during augmented …
metabolic dilators. We hypothesized that coronary vasodilation during augmented …
The contribution of nitric oxide to exercise hyperemia in the human forearm
MB Gordon, R Jain, JA Beckman… - Vascular …, 2002 - journals.sagepub.com
The contribution of nitric oxide (NO) to exercise-induced hyperemia is debated. Previous
conclusions that nitric oxide synthase (NOS) inhibition reduces endothelium-dependent …
conclusions that nitric oxide synthase (NOS) inhibition reduces endothelium-dependent …
Endothelial nitric oxide synthase (NOS) deficiency affects energy metabolism pattern in murine oxidative skeletal muscle
I Momken, D Fortin, B Serrurier, X Bigard… - Biochemical …, 2002 - portlandpress.com
Oxidative capacity of muscles correlates with capillary density and with microcirculation,
which in turn depend on various regulatory factors, including NO generated by endothelial …
which in turn depend on various regulatory factors, including NO generated by endothelial …
Transcatheter closure of coronary artery to pulmonary artery fistula using covered stents
AS Mullasari, CV Umesan, KJ Kumar - Heart, 2002 - heart.bmj.com
Objective: To investigate whether blood flow in normal and post-stenotic coronary arteries is
altered by therapeutic doses of the sulfonylurea agent glibenclamide. Patients: 12 patients …
altered by therapeutic doses of the sulfonylurea agent glibenclamide. Patients: 12 patients …